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CHAPTER 1: HYPOTHESIS, SPECIFIC AIMS & INTRODUCTION
Soy isoflavones are natural compounds extracted from soybeans and have
demonstrated chemoprotective effects and anti-cancer properties (1). In addition, Dr.
Hillman’s lab has recently shown that soy isoflavones act as radioprotectants of normal
lung tissues when given in conjunction with radiation therapy. In a mouse model of lung
tumors and in naïve mice, soy isoflavones reduced the extent of pneumonitis and
fibrosis caused by radiation damage to lung tissue (2,3,4).
Hypothesis:

Based on previous studies showing mitigation of radiation-induced

pneumonitis and fibrosis by soy isoflavones, we hypothesized that soy isoflavones could
provide radioprotection of normal esophageal tissues from radiation-induced tissue
damage. To address this hypothesis, we have examined esophageal tissues from naïve
mice

treated

with

radiation

and

soy

isoflavones

using

histological

and

immunohistochemistry methods.
The specific aims of my research project were:
1) To characterize the histopathological changes of radiation-induced damage in
esophagus.
2) To investigate the effect of soy isoflavones on reducing tissue damage in esophagus.
Clinical Significance:

Prevalence and Clinical Presentation of Radiation

Esophagitis
Radiation-induced toxicity to normal esophageal tissue is a dose-limiting side effect
of radiotherapy for cancers of the thorax as well as head and neck. Based on Alevronta
et al., the esophagus has dose-dependent levels of toxicity (5), and this involves tissue
responses to different radiation strategies – single high dose, hyperfractionated, and
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hypofractionated. Additionally, radiation toxicity in the esophagus can be exacerbated
by the addition of one or more chemotherapeutic drugs to the radiation treatment. (6).
In a clinical report conducted by Werner-Wasik et al. (7), radiation esophagitis is a
highly common ailment experienced by most patients undergoing cancer therapy.
Werner-Wasik identified that 33% of non-small cell lung cancer patients (NSCLC)
receiving chemoradiation developed grade 3 or higher radiation esophagitis, but 95% of
patients developed some level of radiation esophagitis (grade 1-4) (7) (see table 1
below).

Table 1. RTOG Grading Scale with Esophagus Radiation Toxicity & Werner-Wasik
Study Results
RTOG
Associated Clinical Symptoms of From Werner-Wasik Study:
Grade
Radiation Esophagitis
% of Total Patients
Experiencing Symptoms*
Grade 1
mild dysphagia or odynophagia/may 20%
require topical anesthetic or non-narcotic
analgesic/may require soft diet
Grade 2
moderate dysphagia/odynophagia/may 41%
require narcotic analgesics/may require
puree or liquid diet
Grade 3
severe dysphagia/odynophagia with 31%
dehydration or weight loss (more than
15% from pretreatment baseline)
requiring N-G feeding tube, i.v. fluids or
hyperalimentation
Grade 4
complete
obstruction,
ulceration, 2%
perforation, fistula
*Findings from Werner-Wasik et al. study found only 5% of patients did not experience any level of
radiation esophagitis (7).

As described in Table 1., radiation-induced esophagitis presents with acute and/or
chronic clinical symptoms, which include odynophagia (irritation and burning sensation
upon swallowing) and dysphagia (difficulties in the function of swallowing).
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Odynophagia symptoms usually have a rapid onset, and can ultimately be doselimiting, presenting a serious challenge for radiation oncologists to follow through with
radiation regimens and commonly results in ‘premature’ (early) termination of radiation
treatment (7,18). Odynophagia can be attributed to one or many of the following
histological changes from radiation insult: rapid mucosal epithelium depletion, limited
basal cell proliferation for epithelial repopulation, and tissue ulceration. (8,9,10,11)
Alternatively, dysphagia results from an acute or chronic tissue response to radiation
injury and produces a mechanical restriction (and subsequent discomfort) in the action
of swallowing. First, in an early response to radiation as seen in many tissues, the
esophagus undergoes extensive tissue edema, which is a hallmark of radiation induced
tissue damage (8,9,12,20,21).

Radiation produces a cyclic, chronic inflammatory

response, which includes the deposition of collagen and reconstitution of extracellular
matrix compartments (13). Accumulation of collagen and extracellular matrix
components over a long period of time explains long-term development of esophageal
strictures, an ailment that emerges months to years after radiation treatment (5,6,8,13).
Ultimately, whether it’s sudden tissue swelling from an edematous response, or lateforming regions of inappropriate collagen deposition within submucosal tissue layers,
radiation-induced tissue damage has multiple events contributing to dysphagia, and
limiting the esophagus’s essential role as an organ.
In summary, esophagitis is an early side effect of radiation or chemoradiation,
causing pain, difficulties in swallowing and eating, and dehydration, and in the chronic
phase, strictures may develop. These symptoms could lead to early interruption of
radiation treatment, limiting the efficacy of radiation therapy. Therefore, it is imperative
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to design strategies to alleviate the clinical symptoms of radiation-induced toxicity to the
normal esophagus.
Soy Mitigates Radiation Injury to Normal Lung
Our lab has observed the effect of soy isoflavones to act as an anticancer agent and
enhance radiation-induced cancer cell killing in studies in vitro and in vivo in tumor
models of prostate cancer, renal cancer, and lung cancer (14,15,16). In addition to
radiosensitizing tumor cells, studies in lung tumor models demonstrated that soy
isoflavones mitigate radiation-induced pneumonitis and fibrosis in normal lung tissue.
This differential effect of soy isoflavones on cancer cells versus normal tissue was
shown in an orthotopic murine model of lung cancer, which involves soy increasing
radiation-induced destruction of lung tumor nodules while mitigating vascular damage,
inflammation, and fibrosis caused by radiation in normal lung tissue. (2,3).
To further investigate the radioprotective effects of soy isoflavones on lungs from
naïve mice, thoracic irradiation at high doses of 10 Gy or 12 Gy administered alone or in
combination with soy isoflavones, given prior and after irradiation, protected the lungs
against adverse effects of radiation. Soy isoflavones provided many radioprotective
effects, including reduced hair loss, restored respiratory function (breathing rates
comparable to control), reduced pneumonitis (i.e. thickening of alveolar septa),
decreased inflammatory infiltrates, and decreased lung fibrosis (4).

These findings

within normal lung tissue are indicative of early and late effects of radiation-induced
tissue injury and subsequent inflammatory response, and support a radioprotective role
for soy isoflavones in the context of pneumonitis and pulmonary fibrosis, and potentially
in overall radiation-induced toxicity.
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The radiation damage and inflammatory response seen in these lung studies is one
example of the radiation-induced tissue injury and associated organ dysfunction, either
as sudden thickening of alveolar septa and progressive accumulation of fibrotic collagen
in the tissue microenvironment. However, as the lung studies have suggested, soy
isoflavones have the capacity to affect multiple aspects of the inflammatory-mediated
outcome to radiation injury, and could potentially play a role in alleviating tissue injury in
other thoracic organs.
Goals of Study and Overview of Findings
Given the severity of esophagitis caused by radiation in lung cancer patients, we
have now investigated whether soy isoflavones could reduce the tissue damage in
normal esophagus. These studies were conducted in naïve immunocompetent mice
(non tumor-bearing), using conditions of high-dose radiation at 10 Gy or 25 Gy to detect
significant tissue damage, which have been shown to result in greater toxicity in clinical
studies. (17). Soy isoflavones were administered to mice in a controlled dose given by
gavage prior to and after radiation for up to 4 months.

Esophageal tissues were

obtained at different time points after radiation from untreated mice and mice treated
with soy isoflavones alone, radiation alone, and combined radiation and soy to evaluate
the effect of combined therapy compared to single therapy.
Using immunostaining techniques, we have defined the histopathological changes
induced by radiation in multiple tissue layers of the esophagus. This included
disruptions to the mucosal epithelium, lamina propria, muscularis mucosa and
submucosa tissue layers. Our studies showed that soy isoflavones reduced the extent
of damage to the various esophageal tissue layers and confirmed a role for soy
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isoflavones as a complementary and safe approach to improve the efficacy of
radiotherapy for lung cancer.
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CHAPTER 2: MATERIALS AND METHODS
Mice
Female C57BL/6 mice of 5-6 week old (Harlan, Indianapolis, IN) were housed and
handled in animal facilities accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC). Animal protocol was approved by
the Institutional Animal Care and Use Committee (IACUC).
Soy Isoflavones
The soy isoflavones mixture G-4660 used is a pure extract of 98.16% isoflavones
from soybeans consisting of 83.3% genistein, 14.6% daidzein and 0.26% glycitein
(manufactured by Organic Technologies and obtained from NIH). The soy isoflavone
mixture was dissolved in dimethyl sulfoxide (DMSO) and diluted 1:20 in sesame seed oil
just prior to gavage to avoid irritation of the esophagus by DMSO. Mice were orally
treated with soy isoflavones by gavage. Mice in the control and radiation-alone groups
received vehicle alone.
Thoracic Irradiation
Radiation was delivered at a dose of 10 Gy to the mouse thorax including
esophagus, bilateral lungs and mediastinum. Three anesthetized mice, in jigs, were
positioned under a 6.4 mm lead shield with 3 cut-outs in an aluminum frame mounted
on the X-ray machine to permit selective irradiation of the lung in 3 mice at a time, as
previously described (2,3,4). Radiation dose to the thorax and scattered dose to areas
of the mouse outside of the radiation field were carefully monitored. To minimize
backscattering of radiation, the bottom of the aluminum frame that holds the jigs was
hollowed and the backplate of the jig was thinned to 1.6mm thickness. Dose to shielded
regions was reduced to 1% of the dose in the irradiated field. Dose rate was 117.5
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cGy/min and HVL was 2 mm Cu. Photon irradiation was administered using a Siemens
Stabilipan X-ray set (Siemens Medical Systems, Inc) operating at 250 kV, 15 mA, with 1
mm copper beam filtration at a distance of 47.5 cm from the target.
Experimental protocol
Mice were pre-treated with oral soy isoflavones each day for 3 days at a dose of
5mg/day (equivalent to 250mg/kg). On day 4, the thorax was selectively irradiated with
a dose of 10 Gy. Soy treatment was continued on a daily basis for 5 more days at
5mg/day. Then, mice were treated with a lower dose of 1mg/day (equivalent to
50mg/kg), given daily 5 days a week for up to 16 weeks. The rationale for giving a
higher dose of soy isoflavones for pre-treatment and just after radiation is to optimize
the effect of soy based on our previous studies (3,4).
Esophagus tissue preparation for histology
Mice were sacrificed at different time points between 1 to 16 weeks after irradiation.
Esophagi were resected from the proximal end (near the pharynx) to the distal end
(esophageal-gastric junction) within the field of radiation. Distal ends of the esophagus
were marked with blue dye (Davidson Marking System, Bloomington, MN) to ensure
that sections which were irradiated were analyzed. Resected esophagi were fixed and
curved into a U shape for embedding in vertical position in paraffin and transverse
tissue sections were cut.

Esophagus sections were stained with hematoxylin-eosin

(H&E) and examined using a Nikon E-800 microscope. Morphometric measurements of
inner esophageal tissue layers were performed using Image-ProPlus version 6.2
software (Media-Cybernetics) (ref). The effect of radiation and soy on esophageal layers
was evaluated using Masson Trichrome (MT) stain for detecting collagen fibers
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(NovaUltra Kit, IHCWORLD, Woodstock, MD). Histological findings were quantified
using a scoring system on a scale from weak (±), moderate (+), strong (++), and heavy
(+++).
Immunohistochemistry (a-SMA, CD45)
Sections of esophagi were stained by immunohistochemistry. Sections were blocked
with IHC Tek Antibody Diluent, and then incubated with primary purified monoclonal
antibodies directed against α-SMA (Sigma-Aldrich, St Louis, MO), CD45 (eBioscience,
San Diego, CA) and Ki-67 (LifeSpan, Seattle, WA) overnight at 4° C. Sections were
then incubated with biotinylated secondary antibodies (Vector Labs, Burlingame, CA) at
1:300 for 1 hour at room temperature. Staining was amplified with the avidin-biotin
system Vectastain ABC Reagent Kit (Vector Labs) and visualized with the Vector DAB
Substrate Kit for peroxidase (Vector Labs). Sections were counterstained with IHC-Tek
Mayer’s Hematoxylin (IHC World) and mounted with Permount mounting media
(Electron Microscopy Sciences, Hatfield, PA). Esophageal layers were examined on a
Nikon E800 microscope (Nikon Inc., Melville, NY). Histological findings were quantified
using a scoring system on a scale from weak (±), moderate (+), strong (++), and heavy
(+++).
Statistical Analysis
For histological data, differences in the thickness of inner esophageal tissue layers
among the various treatment groups were analyzed by two-tailed unpaired Student’s t
test. A value of p < 0.05 was considered statistically significant and results were
summarized as found in table 1.
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CHAPTER 3: RESULTS
Soy isoflavones reduce radiation damage to esophageal layers.
To assess the effects of irradiation and soy isoflavones on normal esophagus, the
esophagus was resected at 4, 10, and 16 weeks after treatment with either soy alone,
radiation alone, or both radiation and soy isoflavones, and esophagus tissues were
processed for histology studies. A transverse section of the esophagus shows tissue
layers lining the lumen and extending into the 2 skeletal muscle layers of the muscularis
externa (inner circular layer and outer longitudinal layer)(ME, Fig. 1A). Esophageal
tissue layers include the mucosal epithelium (EPI), lamina propria (LP), muscularis
mucosae (MM), submucosa (SM) lining the muscularis externa (ME) (Fig. 1B).
Because alterations induced by radiation were observed in LP, MM, and SM, these
three layers were grouped as inner esophageal layer (IEL) and to evaluate the
differences in IEL between treatment groups, morphometric measurements of IEL were
performed (Table 2). At all time points, esophagus from control mice showed normal
esophageal tissue layer structure and integrity, including a healthy mucosal epithelium,
a thin, dense and continuous LP, and small smooth muscle cells within the MM (Fig.
1C1,2,3, Table 2). Treatment with soy isoflavones did not show alterations in mucosal
epithelium nor IEL, which looked normal compared to untreated esophagi (Fig.
1D1,2,3). In contrast, mouse esophagus treated with radiation caused significant tissue
damage that was observed at 4, 10, and 16 weeks after radiation. Mucosal epithelium
showed disruption in the basal cell layer alignment (circle in Fig. 1E1). Smooth muscle
cells in the MM became enlarged in response to radiation (arrows in Fig. 1E2) and the
IEL became thickened starting at 4 weeks, and increased at 10 and 16 week time points
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(bracket in Fig. 1E3, Table 2).

Esophagus from mice treated with soy isoflavones

before and after radiation showed minimal tissue damage with a mucosal epithelium
and IEL comparable to that in normal esophagus (Fig. 1F1,2,3).

Soy isoflavones

decreased IEL tissue thickening that was seen in mice treated with radiation alone (Fig.
1F3) and differences in IEL tissue thickness were statistically significant (P<0.05) at all
time points compared to radiation alone. (Table 2).
Soy isoflavones reduce disruptions of lamina propria connective tissues caused
by radiation.
Previous studies in our lab showed that soy isoflavones decrease the pulmonary
fibrosis induced by radiation (2,3,4). In order to evaluate the effect of radiation and/or
soy isoflavones on collagen fibers within the lamina propria (LP), esophagus tissue
sections were stained with Masson’s Trichrome stain.

Esophagi from control mice

showed a dense blue, collagen-rich, lamina propria (LP) tissue layer at all time points
(circles in Fig. 2A1,2,3). Similar findings were shown in mice treated with soy
isoflavones alone (circles Fig. 2B1,2,3). Irradiated esophagus revealed that density of
collagen fibers was reduced in the LP (circle in Fig. 2C1) and collagen fibers were seen
infiltrating into muscularis mucosae (MM) layer (arrows in Fig. 2C2,3). Esophagi from
mice treated with irradiation and soy isoflavones showed increased collagen stain
density in LP, and limited positive collagen staining within the MM. These findings were
comparable to that of control and soy isoflavone treated mice, predominately at 4 and
10 weeks after radiation (Fig. 2D1,2,3, Table 3).
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Soy isoflavones decreases smooth muscle cell destruction induced by radiation.
H&E staining and Masson’s Trichrome stain of esophagus tissues showed
hypertrophy and vacuolation of smooth muscle cells in muscularis mucosae (MM). In
order to evaluate smooth muscle cell hypertrophy within the MM tissue layer, tissue
sections were stained by immunohistochemistry using anti-α smooth muscle actin
(αSMA). Untreated esophagus showed normal dense staining of smooth muscle cells
and an overall thin and highly integral MM at all time points (Fig. 3A1,2,3).

Findings

were similar in mice treated with soy isoflavones (Fig. 3B1,2,3). Esophagi from mice
treated with radiation showed smooth muscle cells that had become hypertrophied,
significantly increasing cell size, and cytoplasmic vacuolization at 4 weeks and persisted
through 16 weeks (circles in Fig. 3C1, 3C3). Additionally, irradiated esophagi showed
fragmentation in the continuity of the densely packed smooth muscle cells within the
MM layer at all time points (arrows in Fig. 3C2). Esophagi from mice treated with
combined radiation and soy isoflavones showed reduced smooth muscle cell
hypertrophy, with cell size comparable to control, and limited fragmentation of MM
smooth muscle throughout all time points after radiation treatment (Fig. 3D1,2,3, Table
3).
Soy isoflavones reduce leukocytic infiltration within esophageal tissue layers
after radiation.
In response to radiation-induced tissue injury, infiltration of immune cells to the site
of injury can occur, contributing to the overall inflammatory response. This effect has
been well documented, including previous studies by our lab on radiation-induced lung
injury, resulting in pneumonitis.

These studies found that supplementation of soy
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isoflavones to radiation therapy reduced inflammatory infiltrates within the normal lungs
(2,3,4). In order to evaluate inflammatory infiltration induced by radiation and the effect
of soy isoflavones, esophagus tissue sections were obtained at 4 weeks after treatment
and stained by immunohistochemistry using the pan-leukocyte CD45 marker. Esophagi
from untreated mice and mice treated with soy isoflavones showed no CD45+ cells
within tissue sections (Fig. 4A,B). Irradiated esophagus tissues contained several focal
areas of CD45+ cells at the edge of the mucosal epithelium lining the lamina propria
(LP) (arrows Fig. 4C) and these clusters were found in multiple sites throughout tissue
sections. Esophagi treated with radiation and soy isoflavones showed minimal
infiltration of CD45+ cells (Fig. 4D).
Soy isoflavones mitigates early effects of radiation-induced damage on the
mucosal epithelium.
We have discussed the histopathological changes occurring in response to radiation,
and mitigation by soy isoflavones at 4 to 16 weeks after radiation treatment and at a
single dose of 10 Gy radiation. However, it known that early tissue responses to
radiation-induced injury are highly implicated in the development of acute symptoms
and side effects to radiation treatment (7,8,9,10,11,18). Additionally, a single dose of 10
Gy irradiation is not fully representative of what is used in the clinic, and a fair proportion
of patients develop radiation-induced esophagitis as a result of high doses of radiation
(5,7,8,11). Therefore, it is of high interest to investigate and evaluate the effects of soy
isoflavones at an early time point after radiation and at a higher dose of radiation.
In the following experiment, esophageal tissue sections were evaluated at 1 week
after radiation from mice receiving either 10 Gy or 25 Gy irradiation alone or 10 Gy / 25
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Gy radiation in combination with soy isoflavones. Untreated esophagi showed normal
tissue layers at 1 week after radiation (Fig. 5A1, 5A2), and were comparable to
esophagi analyzed in initial studies at later time points (Fig. 1C). Esophagi from mice
treated with soy isoflavones showed normal, undisturbed tissue layers, similar to control
(Fig. 5B1, 5B2). Esophagus tissue from mice treated with 10 Gy radiation or 25 Gy
irradiation showed multiple alterations to the mucosal epithelium basal cell layer. Basal
cells showed morphological disruptions that were more pronounced in mice treated with
25 Gy radiation. Some basal cells appeared karyorrhexic with a fragmented nucleus
(arrow in Fig. 5D1) and formed giant cells (arrows in Fig. 5D1,2). Other basal cells
appeared to have become hyperplastic, showing active mitosis in the mucosal
epithelium (circles in Fig. 5C1, 5D1). Additionally, in esophagi from 10 Gy or 25 Gy
radiation treatments, inner esophageal layers (IEL) showed increased thickening
(bracket in 5C2) and disruptions in the continuity of mucosal basal cells (dotted lines in
5C2). Esophagi from mice treated with radiation and soy isoflavones showed limited
karryorrhexic basal cells with no giant cells present, a reduced proportion of basal cells
undergoing active proliferation, reduced thickening of IEL, and no disruption in the
alignment of basal cells along the basement membrane (Fig. 5E1,2, 5F1,2).
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CHAPTER 4: DISCUSSION AND CONCLUSION
For NSCLC patients, radiation-induced esophagitis presents a major radiation doselimiting challenge to radiation oncologists and disrupts efficacy of radiation regimens (5).
Multiple studies by Gomez et al. has associated radiation-induced esophagitis
inflammatory

cytokine

profiles,

inflammatory

markers,

chemoradiation-induced

neutropenia, and gene polymorphisms as a result of inflammatory responses (19).
Nearly all patients experience some level of esophageal toxicity within the field of their
radiation treatment, and present with varying severity of odynophagia and dysphagia as
a result of tissue injury and inflammation (7), necessitating the need for intervention and
effective therapeutics.
Our lab has previously demonstrated the radioprotective effect of soy isoflavones in
lung tumor bearing mice and in naïve bearing mice, mitigating radiation-induced
pneumonitis and pulmonary fibrosis in normal lung tissue (2,3,4).

Based on these

findings, the goals of my master’s research project were to identify and characterize the
histopathological changes that occur in normal esophagus tissue in response to
radiation injury, and to investigate the effect of soy isoflavones on reducing tissue
damage in the esophagus.

These aims are based on the hypothesis that soy

isoflavones may provide radioprotection of normal esophageal tissues from radiationinduced tissue damage.
In order to assess histopathology of normal tissue, studies were performed in naïve,
non-tumor bearing mice.

Mice were treated with a high dose of 10 Gy thoracic

irradiation and an effective dose of soy isoflavones (1mg/day)(2,3,4), given prior and
after radiation. In separate experiments, tissues were evaluated at 4, 10, and 16 weeks
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after radiation to address late effects of radiation or at 1 week after radiation to address
early effects of radiation.
Soy isoflavones reduce esophageal tissue edema in response to radiation injury.
We have identified significant alterations in esophageal tissue layers caused by
radiation injury.

In particular, thickening of the inner esophageal layers (IEL) was

observed from 4 to 16 weeks after radiation. These findings were also found already at
1 week after radiation in separate experiments and could be the result of tissue edema.
A hallmark of radiation-induced tissue damage in multiple organ systems includes tissue
edema, or the subcompartmental accumulation of fluids, ultimately causing a swelling of
one or more tissue compartments (20,21). The edematous response of esophageal
tissues is a highly documented phenomenon and esophageal swelling can be
considered a contributor to dysphagia caused by radiation treatment (8,9,12). Our
observation in irradiated mouse esophagus also reflected an edematous response.
Interestingly, this thickening of IEL was significantly decreased by complementing
radiation with soy isoflavones, suggesting that soy isoflavones influence one or many
events associated with fluid accumulation from radiation-induced tissue damage.
Soy isoflavones decrease collagen disintegration in lamina propria and limit
collagen infiltration into muscularis mucosae.
Reduced density of Masson’s trichrome staining of collagen in lamina propria a
different time points after radiation suggested that radiation causes collagen disruption
and subsequent remodeling of the fibrous lamina propria compartment. Additionally,
radiation-induced tissue damage cause the infiltration of collagen fibers between
hypertrophied smooth muscle cells in muscularis mucosae. These effects are normal
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responses to radiation-induced tissue injury, and were reduced when radiation
treatment was combined with soy isoflavones. Bentzen et al. describes the remodeling
process a result of radiation tissue damage to include compartmentalized fibrosis (13).
Fibrosis is a process to repair tissue damage and is a result of limited replenishment by
existing stem cells. This process involves a cytokine cascade that generates excessive
collagen and extra cellular matrix deposition into sites of dead cells (12,13).

The

process of fibrosis is necessary to maintain structural integrity, but at a serious cost as it
replaces functional cells with non-functional tissue, therefore limiting the physiological
capabilities of a damaged organ. Fibrotic accumulation of collagen over long periods of
time—months to years—can lead to esophageal stricture formation and can present as
dysphagia, a chronic symptom from radiation (5,6,8,13).

Therefore, soy isoflavone

supplementation to radiation therapy could be applied to reduce the progression of longterm stricture formation as a result of radiation-induced fibrosis.
Soy isoflavones mitigate radiation-induced smooth muscle cell hypertrophy in
muscularis mucosae.
By immunohistochemical staining of smooth muscle cells within the muscularis
mucosae, we observed changes caused by radiation, including increased cellular size,
or hypertrophy, of smooth muscle cells with fragmentation in the continuity of smooth
muscle layer. This effect was seen as early as 1 week after radiation and persisted up
to 16 weeks after radiation. However, smooth muscle cell disruption was reduced in
tissues with combined treatment of radiation and soy isoflavones at all time points.
Smooth muscle cell hypertrophy in response to radiation has been documented and
observed in multiple organs containing smooth muscle (20,21). But specific studies
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investigating the pathological events related to dysfunctional smooth muscle cells from
radiation injury remain limited. Preservation of smooth muscle cell structure by soy
isoflavones, both at the cellular level by reducing hypertrophy, and at the tissue level by
reducing fragmentation, could provide functional conservation of muscularis mucosae
smooth muscle, limiting the development and progression of radiation-induced
dysphagia.
Soy isoflavones abrogate leukocyte infiltration at the edge of mucosal epithelium.
Assessment of radiation-induced damage to esophagus demonstrated significant
infiltration of leukocytes in lamina propria at the edge of the mucosal epithelium,
whereas tissue treated with radiation and soy isoflavones showed minimal presence of
leukocytes.

Inflammatory infiltration is known to be a normal response by various

tissues to radiation injury (12,13,22) and was reported to occur in our previous studies
on radiation-induced toxicity to the lungs (2,3,4). The initial insult of radiation initiates
an inflammatory phase with chemokine and cytokine (TNF-α, IL-6, IL-1β) production to
attract inflammatory cells to site of injury. This initial response occurs within hours and
may extend over months (12,13,22) in conjunction with tissue edema, cellular swelling,
lymphocytic infiltration, and apoptotic cell induction followed by tissue regeneration by
stem cells (12). Based on our findings that soy isoflavones mitigate the majority of
these events, it is worth investigating if and how soy isoflavones may alter aspects of
the immune system in the context of normal tissue inflammatory responses to radiation.
Additionally, it was reported by McBride et al. that radiation elicits a range of tissue
responses that include a cytokine ‘breeze’, rather than cytokine storm (22). It is shown
that the strength of the inflammatory response is proportional to the intensity of radiation
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treatment (22), and considering the radioprotective effects of soy isoflavones in limiting
leukocyte infiltration shown in our data, future studies may want to evaluate the effects
of soy isoflavones on inflammatory response at higher, clinically relevant, doses of
radiation.
Soy isoflavones limit the disruption of basal cell alignment and continuity.
The regular arrangement of basal cells depend on intracellular tight junctions, which
hold cells together and are the basis for maintaining mucosal tissue barrier functions
(23). Radiation-induced tissue damage included disruption in the alignment of basal
cells within mucosal epithelium, and this trend was seen at both early and late time
points after radiation. In esophagus tissues from mice treated with radiation and soy
isoflavones, the disruption of basal cell alignment was diminished, and resembled the
basal cell continuity found in control. A review examining the role of flavonoids in
intestinal tight junction regulation showed that genistein, the primary isoflavone found in
soy, protected intestinal tight junction barrier function by counteracting disassembly of
occludins induced by oxidative stress and acetylaldehyde (24). These findings could
explain observations that soy isolfavones could reduce radiation-induced disruptions to
mucosal basal cells in normal esophagus, providing maintenance of mucosal barrier
function.
Soy isoflavones reduce the number of radiation-induced abnormal basal cells.
The mucosal epithelial response to radiation injury included cellular changes in basal
cells that were eliminated by combined radiation and soy isoflavone treatment. In
response to radiation, some basal cells became karyorrhexic, where the nucleus
becomes fragmented and precedes the potential cellular apoptosis induction.
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Abnormally dividing basal cells form into giant cells that will ultimately die (12,13,22,28).
Basal cells that have not undergone significant radiation damage, and subsequent
induction of apoptotic cell death, will remain as actively dividing cells. As a function of
actively replenishing the mucosal epithelium, these remaining basal cells may become
hyperplastic in order to compensate for neighboring basal cells that have died and no
longer contributed to replenishing mucosal epithelial cells. (12,25,28). Drastic changes
in basal cell morphology reflecting radiation damage were pronounced with a higher
dose of 25 Gy irradiation, and were seen already at 1 week after radiation.
Soy isoflavones showed reduced presence of both karryorrhexic cells and actively
dividing cells. This effect was also observed with a higher dose of 25 Gy, confirming
soy isoflavone’s radioprotective role in mucosal epithelium. This could be explained by
two previous studies identifying the role of genistein in reducing apoptosis induction in
normal testicular mucosal tissues (28) and intestinal mucosal tissues (29). Limiting the
overwhelming induction of basal cell apoptosis in response to radiation by soy
isoflavones could be of great benefit in maintaining the integrity of mucosal epithelium
and reducing rapid and prolonged epithelial depletion implicated in radiation-induced
odynophagia, and warrant further investigation.
Summary and Conclusions
Taken together, these studies show that soy isoflavones provide a radioprotective
role in numerous aspects of radiation-induced tissue damage and subsequent
inflammatory responses. Multiple radiation-induced histopathological alterations of the
normal esophagus were identified, including tissue edema, collagen remodeling and
disintegration, smooth muscle cell hypertrophy and fragmentation, inflammatory
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leukocyte infiltration, and disruption to mucosal basal cell morphology and function. By
treating mice with combined therapy of radiation and soy isolfavones, esophageal
tissues were comparable to that of control esophagi, showing limited tissue edema,
dense collagen fibers that make up a thin lamina propria, reduced smooth muscle cell
hypertrophy and continuous smooth muscle throughout the muscularis mucosae,
minimal inflammatory leukocyte infiltration at the edge of the mucosal epithelium, and
maintenance of alignment with decreased numbers of both karryorrhexic and
hyperplastic mucosal basal cells. While many of these changes are mediated by an
inflammatory response that varies from patient to patient upon radiation injury, nearly all
patients receiving thoracic radiation experience some level of radiation-induced
esophagitis. These findings can translate into the potential application of soy isoflavone
supplementation during radiation therapy with the goal to mitigate the harmful side
effects of radiation-induced tissue damage to normal esophagus. Further investigation
of the various radioprotective properties of soy isoflavones in preserving normal
esophagus tissue and organ function is warranted.
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CHAPTER 5: FIGURES, TABLES, AND LEGENDS
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FIGURE 1. H&E staining of esophagus tissue sections treated with soy, radiation, and radiation +
soy. Esophagi tissue sections were obtained from control mice and mice treated with soy or radiation
(Rad) or radiation + soy (Soy + Rad) at 4, 10, and 16 weeks after radiation. Sections were stained with
H&E. (A). Transverse tissue section of the esophagus at low magnification [10x]. (B). Esophageal tissue
layers include the mucosal epithelium (EPI), lamina propria (LP), muscularis mucosae (MM), submucosa
(SM) lining the muscularis externa (ME) [x100]. Because alterations induced by radiation were observed
in LP, MM, and SM, these three layers were grouped as inner esophageal layer (IEL). (C). Sections from
control mice showing normal morphology of the different tissue layers. (D). Sections from mice treated
with soy are showing mild changes in IEL and EPI. (E). Sections from mice treated with radiation
showing alterations in the EPI with disruptions in the alignment of epithelial cells in the basal cell layer
(circle in E.1). In the MM layer, consisting of smooth muscle cells, hypertrophy and cytoplasmic
vacuolation were observed (arrows in E.2). Overall thickening of IEL and extensive vacuolation were
observed at 4, 10, and 16 weeks after radiation (brackets in E.3). (F) Sections from mice treated with
radiation + soy showing less alterations than in radiation alone, mostly in LP and MM layers. [All
magnifications x100].
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Treatment
Control
Soy alone
RT alone
RT+Soy

Inner Esophageal Layer Thickness (Mean µm ± SEM)
Day 28
Day 70
Day 112
15.77 ± 0.40
22.74 ± 0.58*
25.13 ± 0.54
20.58 ± 0.59
21.80 ± 0.64*
30.24 ± 1.08**
30.66 ± 0.67
41.54 ± 1.18
40.43 ± 0.91
25.54 ± 0.67
27.03 ± 0.74
33.28 ± 0.80**

TABLE 2. Morphometric measurements of inner esophageal tissue layers. Using Image Pro Plus
software analysis of H&E slides, the thickness of the IEL was quantified in 5 fields of 100x for each
mouse esophagus. Data computer on mouse esophagus was from 4 representative mice from 2
separate experiments, yielding 100 measurements per treatment. Student’s T-test revealed significant
differences between all treatment groups except those denoted by * and **.
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FIGURE 2. Effect of soy and radiation on fibrotic connective tissue layers of esophagus.
Esophagus tissue sections obtained from the experiments described in figure 1 were stained with
Masson’s Trichrome for detection of collagen fibers within the LP and SM connective tissues. (A)
Sections from control mice showed normal, dense and well organized layers of collagen fibers within the
LP at all time points [x100]. (B) Sections from mice treated with soy showed LP and SM fibrous layers
similar to that of control. (C) Sections from mice treated with radiation showed alterations in LP and SM
with disruptions in the integrity of connective collagen fibers including thickening of LP and decreased
density of collagen fibers as well as focal infiltration of fibers around smooth muscle cells within the MM.
(D) Sections from mice treated with radiation + soy showed reduced collagen infiltration into MM smooth
muscle compared to radiation and a higher density of fibers that is comparable to LP of control and soytreated esophagus. [All magnifications x100].
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FIGURE 3. Effect of soy and radiation on smooth muscle cells in muscularis mucosae and
epithelial layer of esophagus. Esophagus tissue sections obtained from the experiments described in
figure 1 were stained with anti-αSMA by IHC for detection of smooth muscle cells in MM. (A) Sections
from control mice showed normal thin MM layer with dense staining of smooth muscle cells separating
the LP and SM. (B) Sections from mice treated with soy showed normal MM similar to control. (C)
Radiation caused obvious thickening of LP and MM seen by MT. Smooth muscle cell hypertrophy (circles
in C.1), large empty vacuoles, and both rounding up and condensation of smooth muscle cell nuclei were
evident in MM. Interruptions in the integrity of MM layer were also observed (arrows in C.2). (D) Sections
from mice treated with radiation + soy showed reduced smooth muscle cell hypertrophy and limited
disintegration of MM compared to radiation alone. [All magnifications x100].
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Fibrosis Collagen
Density
(Masson Trichrome Lamina Propria)

Smooth Muscle Cell
Hypertrophy
(α-SMA - Muscularis Mucosa)

D28
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D112
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++

++

++

±

±

±
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++

++

++

±

±

+
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+

+

+

++

+++

+++

Rad +
Soy

++

++
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Table 3. Summary and Quantification of Histological Observations. Histological findings from
experiments presented in Figures 2 and 3 were quantified. The extent of fibrosis (collagen density) and
MM damage (smooth muscle cell hypertrophy) were scaled from weak (±), moderate (+), strong (++), to
heavy (+++).
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C.Rad
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FIGURE 4. Leukocyte infiltration in esophageal tissues treated with soy and radiation. Esophagi
tissue sections were obtained from control mice and mice treated with soy or radiation (Rad) or radiation
+ soy (Soy + Rad) at 4 weeks after radiation. Esophagus tissues were stained with anti-CD45 by IHC for
detection of leukocytes at the border between LP and EPI. (A) Sections from control mice showed no
staining of CD45+ cells within the LP nor EPI tissue layers, and (B) similar results were shown in mice
treated with soy. (C) Sections from mice treated with radiation showed focal CD45+ leukocyte infiltration
in LP and forming clusters at the edge of EPI basal layer (arrows in C). (D) Sections from mice treated
with radiation + soy showed minimal CD45+ cell infiltrates comparable to control and soy-treated
esophagus. [All magnifications x100].
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FIGURE 5. Early effects of soy on esophageal tissues treated with 25 Gy radiation compared to 10
Gy radiation. Esophagi tissue sections were obtained from control mice and mice treated with soy or
radiation (Rad) or radiation + soy (Soy + Rad) at 1 week after a radiation dose of 10Gy or 25Gy. Sections
were stained with H&E and each treatment includes two representative images. (A) Sections from control
mice show healthy esophagus tissue layers, including normal mucosal epithelium, including normal basal
cell shape, size and morphology. (B) Sections from mice treated with soy showed normal mucosal
epithelium comparable to control mice. (C) Sections from mice treated with 10Gy radiation showed
several changes in the mucosal epithelium, and (D) a higher dose of 25Gy radiation caused greater
alterations in the EPI mucosal layer, including basal cell hyperplasia showing increased mitosis (circles in
C.1 and D.1), karyorrhexic basal cells and formation into giant cells (arrows in D.1 and D.2), and
disruptions to basal cell basement membrane continuity (dotted lines in C.2). Additionally, tissue sections
showed large regions of increased thickness of IEL, including LP and MM (brackets in C.2). (E, F)
Sections from mice receiving combined treatment of 10Gy or 25Gy radiation with soy showed decreased
alterations in mucosal basal cell morphology, including reduced basal cell hyperplasia, few to no giant cell
formation, and fewer regions of disrupted basal cell basement membrane continuity, similar to control and
soy treated mice. Additionally, sections from mice having soy treatment with both radiation doses
showed decreased thickening of the IEL.
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Lung cancer patients receiving radiotherapy present with acute and chronic
esophagitis, resulting in pain and difficulties swallowing.

These effects are due to

radiation injury to the normal tissues in the esophagus. Our previous studies in preclinical models of lung cancer and naïve mice have shown that soy isoflavones
alleviates radiation-induced toxicity to normal lung, including a decrease in pneumonitis
and fibrosis. In this study, we have investigated whether radiation-induced esophagitis
can be reduced by soy isoflavones. C57BL/6 mice were treated with 10 Gy or 25 Gy for
thoracic irradiation and soy isoflavones given daily at 1mg/mouse up to 16 weeks.
Esophagi were resected at various time points (1,4,10,16 weeks post-radiation).
Damage to esophageal tissues was assessed by H&E staining and Masson’s
Trichrome.

The effects on smooth muscle cells and leukocyte infiltration were

determined by immunohistochemistry using anti-aSMA and anti-CD45.

Histological

analysis revealed esophagus tissue edema and inflammatory leukocyte infiltration.
Specific findings included alterations in the mucosal epithelium, connective tissue
disruption in the lamina propria, and smooth muscle cell hypertrophy in the muscularis
mucosa. Radiation-induced tissue injuries were reduced by combining soy isoflavones
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with radiation treatments. Quantitative evaluation of thickened, edematous tissue layers
was performed by morphometric measurements. Analysis of 100 measurements per
treatment group revealed a significant decrease in the thickness of esophageal layers in
irradiated

mice

treated

with

soy

(25.54um±0.67SEM)

to

radiation

alone

(30.66um±0.67SEM) (p<0.0001). Radiation-induced damage presented within 1 week
and progressively worsened with time, being more pronounced with 25 Gy compared to
10 Gy, but was also decreased by soy supplementation. Thoracic irradiation caused
injury to multiple layers of the esophagus, and these effects were mitigated by soy
isoflavones. These findings suggest that soy isoflavones have a radioprotective effect
on the esophagus, mitigating the early and late effects seen in radiation-induced
esophagitis.
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